SCHEMBL21135671

SCHEMBL21135671

Cc1c(N)c(C)c(S(=O)(=O)Nc2ccccc2C(=O)O)c(C)c1N

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.72
MEN1 O00255 8/20 0.72
ALDH1A1 P00352 6/20 0.72
HSD17B10 Q99714 4/20 0.72
KDM4E B2RXH2 4/20 0.72
HPGD P15428 3/20 0.72
CRHBP P24387 1/20 0.72
CRHR2 Q13324 1/20 0.72
LMNA P02545 3/20 0.52
TDP1 Q9NUW8 3/20 0.50
POLB P06746 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
METAP2 P50579 1/20 0.48
WDR5 P61964 1/20 0.47
ATM Q13315 1/20 0.47
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TP53 P04637 1/20 0.46
GAA P10253 1/20 0.46
TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9678639 0.78 MEN1 (0.74) KMT2AMEN1ALDH1A1HSD17B10KDM4E
SCHEMBL27770316 0.78 MEN1 (0.63) KMT2AMEN1ALDH1A1HSD17B10KDM4E
SCHEMBL9618720 0.78 ALDH1A1 (0.74) KMT2AMEN1ALDH1A1HSD17B10KDM4E
SCHEMBL11246570 0.77 ALDH1A1 (0.68) KMT2AMEN1ALDH1A1HSD17B10KDM4E
SCHEMBL12659878 0.77 ALDH1A1 (0.59) KMT2AMEN1ALDH1A1HSD17B10KDM4E
SCHEMBL21135669 0.77 KMT2A (0.51) KMT2AMEN1ALDH1A1LMNAPOLB
SCHEMBL1466906 0.75 ALDH1A1 (0.72) KMT2AMEN1ALDH1A1HSD17B10KDM4E
SCHEMBL1688339 0.75 METAP2 (0.71) KMT2AMEN1ALDH1A1HSD17B10KDM4E
SCHEMBL15822907 0.75 ALDH1A1 (0.68) KMT2AMEN1ALDH1A1HSD17B10KDM4E
SCHEMBL3554591 0.74 ALDH1A1 (0.60) KMT2AMEN1ALDH1A1HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10717706-B2 M-phenylenediamine compound and method for producing polymer compound using same FUJIFILM CORPORATION (JP) 2020-07-21 US disclosed
US-20190177270-A1 NOVEL M-PHENYLENEDIAMINE COMPOUND AND METHOD FOR PRODUCING POLYMER COMPOUND USING SAME FUJIFILM CORPORATION (JP) 2019-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190177270-A1 NOVEL M-PHENYLENEDIAMINE COMPOUND AND METHOD FOR PRODUCING POLYMER COMPOUND USING SAME PNMT, PRMT9, HRH3 KMT2A 589/4885MEN1 179/4885ALDH1A1 3083/4885
US-10717706-B2 M-phenylenediamine compound and method for producing polymer compound using same PNMT, HRH3, PRMT9 KMT2A 505/4885MEN1 134/4885ALDH1A1 3143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.